Aspirin and Enalapril in Microalbuminuric Type 2 Diabetes Mellitus Patients

Summary

Research design: randomized, double-blind, placebo-controlled crossover study to evaluate the putative interference of low-dose aspirin (for 8 weeks) on enalapril antiproteinuric properties in microalbuminuric type 2 diabetes mellitus patients

Timeline

Start

2003-03

Primary completion

—

Completion

2007-01

Drugs

Indications